Serum CA-125 Level after 6 Cycles of Primary Adjuvant Chemotherapy Is a Useful Prognostic Factor for Complete Responders’ Survival in Patients with Advanced Epithelial Ovarian Cancer

Publisher： Karger

E-ISSN： 2296-5262|31|6|315-320

ISSN： 2296-5270

Source： Oncology Research and Treatment, Vol.31, Iss.6, 2008-05, pp. : 315-320

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Does the Number of Neoadjuvant Chemotherapy Cycles before Interval Debulking Surgery Influence Survival in Advanced Ovarian Cancer?

By  

Oncology, Vol. 91, Iss. 6, 2016-10 ,pp. : 331-340

Karger

Access to resources Recommend Favorite

The prognostic value of perioperative, pre‐systemic therapy CA125 levels in patients with high‐grade serous ovarian cancer

By  

International Federation of Gynecology and Obstetrics, Vol. 140, Iss. 2, 2018-02 ,pp. : 247-252

John Wiley & Sons Inc

Access to resources Recommend Favorite

Intraperitoneal Paclitaxel Is Useful as Adjuvant Chemotherapy for Advanced Gastric Cancer with Serosal Exposure

By  

Case Reports in Oncology, Vol. 7, Iss. 1, 2014-01 ,pp. : 58-64

Karger

Access to resources Recommend Favorite

Improved Overall Survival with 12 Cycles of Single-Agent Paclitaxel Maintenance Therapy following a Complete Response to Induction Chemotherapy in Advanced Ovarian Carcinoma

By  

Oncology, Vol. 78, Iss. 5-6, 2010-08 ,pp. : 389-393

Karger

Access to resources Recommend Favorite

Elevated Serum CA-125 in a Patient with Follicular Lymphoma and a History of Ovarian Cancer

By  

Case Reports in Oncology, Vol. 4, Iss. 1, 2011-03 ,pp. : 172-174

Karger

Access to resources Recommend Favorite